Table of Contents
Volume 5 | Issue 4
Publication Date: March 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorial | ||
215-216 |
Report of the Third International Workshop on Waldenström’s Macroglobulinemia Steven P. Treon, Pierre Morel, Veronique Leblond, Jean-Paul Fermand |
|
Comprehensive Reviews | ||
217-219 |
Origins of Waldenström’s Macroglobulinemia: Does It Arise from an Unusual B-Cell Precursor Jitra Kriangkum, Brian J. Taylor, Tony Reiman, Andrew R. Belch, Linda M. Pilarski |
|
220-224 |
Clinicopathologic Features of Waldenström’s Macroglobulinemia and Marginal Zone Lymphoma: Are They Distinct or the Same Entity? Françoise Berger, Alexandra Traverse-Glehen, Pascale Felman, Evelyne Callet-Bauchu, Lucille Baseggio, Sophie Gazzo, Catherine Thieblemont, Martine Ffrench, Jean Pierre Magaud, Gilles Salles, Bertrand Coiffier |
|
225-229 |
Autoantibody Activity in Waldenström’s Macroglobulinemia Marvin J. Stone, Giampaolo Merlini, Virginia Pascual |
|
Original Contributions | ||
230-234 |
Cytogenetics of Familial Waldenström’s Macroglobulinemia: In Pursuit of an Understanding of Genetic Predisposition Mary L. McMaster, Therese Giambarresi, Linda Vasquez, Alisa M. Goldstein, Margaret A. Tucker |
|
235-240 |
Differential Diagnosis of Waldenström’s Macroglobulinemia and Other B-Cell Disorders Gerassimos A. Pangalis, Maria-Christina Kyrtsonis, Flora N. Kontopidou, Marina P. Siakantaris, Maria N. Dimopoulou, Theodoros P. Vassilakopoulos, Tatiana Tzenou, Styliani Kokoris, Evangelia Dimitriadou, Christina Kalpadakis, Kaliroe Tsalimalma, Panagiotis Tsaftaridis, Panagiotis Panayiotidis, Maria K. Angelopoulou |
|
241-245 |
Immunophenotypic and Cytogenetic Comparison of Waldenström’s Macroglobulinemia with Splenic Marginal Zone Lymphoma Enrique M. Ocio, Jesús M. Hernández, Gema Mateo, Mariá L. Sánchez, Belén González, Belén Vidriales, Norma C. Gutiérrez, Alberto Orfao, Jesús F. San Miguel |
|
246-249 |
CD5, CD10, and CD23 Expression in Waldenström’s Macroglobulinemia Zachary R. Hunter, Andrew R. Branagan, Robert Manning, Christopher J. Patterson, Daniel Ditzel Santos, Olivier Tournilhac, David M. Dorfman, Steven P. Treon |
|
250-252 |
Cell Cycle Analysis of Waldenström’s Macroglobulinemia Enrique M. Ocio, Gema Mateo, Belén Vidriales, M. Consuelo López-Berges, Ramón García-Sanz, Jesús M. Hernández, Alberto Orfao, Jesús F. San Miguel |
|
253-256 |
Potential Impact of a Single Nucleotide Polymorphism in the Hyaluronan Synthase 1 Gene in Waldenström’s Macroglobulinemia Sophia Adamia, Steven P. Treon, Tony Reiman, Olivier Tournilhac, Carrie McQuarrie, Michael J. Mant, Andrew R. Belch, Linda M. Pilarski |
|
257-260 |
Prognostic Factors and Predictors of Outcome of Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance Robert A. Kyle, S. Vincent Rajkumar, Terry M. Therneau, Dirk R. Larson, Matthew F. Plevak, L. Joseph Melton III |
|
261-264 |
Clinical Characteristics and Outcome of Immunoglobulin M–Related Disorders Clara Cesana, Luciana Barbarano, Sara Miqueleiz, Camilla Lucchesini, Francesca Ricci, Marzia Varettoni, Davide Filippini, Mario Lazzarino, Enrica Morra |
|
265-269 |
Prognostic Factors for Transformation in Asymptomatic Immunoglobulin M Monoclonal Gammopathies Enrica Morra, Clara Cesana, Catherine Klersy, Luciana Barbarano, Sara Miqueleiz, Marzia Varettoni, Camilla Lucchesini, Francesca Ricci, Mario Lazzarino |
|
270-272 |
Predictive Factors for Response to Rituximab in Waldenström’s Macroglobulinemia Meletios A. Dimopoulos, Athanasios Anagnostopoulos, Constantinos Zervas, Marie C. Kyrtsonis, Athanasios Zomas, Constantinos Bourantas, Nicolaos Anagnostopoulos, Gerassimos Pangalis |
|
273-277 |
CHOP plus Rituximab Therapy in Waldenström’s Macroglobulinemia Steven P. Treon, Zachary Hunter, Andrew R. Branagan |
|
278-281 |
CD52 Expression in Waldenström’s Macroglobulinemia: Implications for Alemtuzumab Therapy and Response Assessment Roger G. Owen, Peter Hillmen, Andy C. Rawstron |
|
282-284 |
Early Results of a Phase I Trial of Oblimersen Sodium for Relapsed or Refractory Waldenström’s Macroglobulinemia Morie A. Gertz, Susan M. Geyer, Ashraf Badros, Brad S. Kahl, Charles Erlichman |
|
Case Report | ||
285-289 |
Immunoglobulin M Myeloma: Evaluation of Molecular Features and Cytokine Expression Kartik Konduri, Surinder S. Sahota, Gavin Babbage, Alex W. Tong, Padmasini Kumar, Joseph T. Newman, Marvin J. Stone |
|
Brief Communication | ||
290-293 |
Cold Agglutinin Disease and Cryoglobulinemia Morie A. Gertz |
|
Current Trial | ||
294-297 |
Phase III Study of Chlorambucil Versus Fludarabine as Initial Therapy for Waldenström’s Macroglobulinemia and Related Disorders Stephen A. Johnson, Roger G. Owen, David G. Oscier, Veronique Leblond, Vincent Levy, Ulrich Jaeger, John F. Seymour |
|